Recent News and Press Releases

01-02

Nov

2024

CEO John Ralston to present Neursantys innovations in neuromotor aging biomarkers and bioelectronic balance restoration at Biomarkers of Aging 2024, Nov 1-2 at Harvard Medical School in Boston.

14-16

Oct

2024

Neursantys CEO John Ralston to present plenary talk on “Wearable device integration of diagnostic sensors and bioelectronic therapeutics for the treatment of neurophysiological conditions” at ISSST 2024 in Edinburgh

06-09

Oct

2024

Neursantys and Jali Medical to Showcase NEURVESTA Bioelectronics Platform at Neuroscience 2024 in Chicago

05

Sept

2024

TechCrunch selects Neursantys as a Startup Battlefield 200 company and TechCrunch Disrupt 2024 Exhibitor

22

Aug

2024

NEURVESTA and Cortex Design unveil development of NEURVESTA bioelectronics platform targeting age-related balance decline

30

July

2024

Humans in Space to showcase Neursantys as Exhibitor and Panelist at ASCEND 2024 in Las Vegas, July 30-Aug 1

27

July

2024

Neursantys receives Pilot Award funding from a2 Collective to accelerate the company’s innovations in AI and aging

12

June

2024

AgeTech Collaborative selects Neursantys as winner of AARP AgeTech Pitch Challenge at 2024 Longevity Venture Summit in San Francisco

03

June

2024

Neursantys partners with Synaptic Neuro Rehabilitation and University of Calgary to pilot groundbreaking bioelectronic treatment for multiple sclerosis

31

May

2024

Neursantys selected to pitch as finalist in AgeTech Pitch Challenge, June 11-12 in San Francisco

14

May

2024

Neursantys to headline session on Human Balance from Early Development to Age-Related Decline at 2024 Annual BOLD Conference in Anaheim, CA.

24

APRIL

2024

Neursantys selected as member of the inaugural Plug and Play Sportstech accelerator program

05

APRIL

2024

LeadingAge California highlights AgeTech applications of the NEURVESTA bioelectronics device

01

APRIL

2024

Neursantys investor Boryung showcases SpaceTech applications of the NEURVESTA bioelectronics device

27

MARCH

2024

University of Calgary and Neursantys highlight links between AgeTech and SpaceTech applications of the NEURVESTA bioelectronics device

26

MARCH

2024

Neursantys to showcase injury treatment, injury prevention, and athlete performance applications of the NEURVESTA bioelectronics platform at Grand Opening of Plug and Play’s new SportsTech office in Frisco Texas.

13-14

MARCH

2024

Neursantys to present at Medtech Innovator 2024 Strategic Road Tour in Los Angeles.

15-17

FEB

2024

Neursantys to showcase NEURVESTA bioelectronic therapy platform at American Physical Therapy Association Meeting APTA-2024 in Boston, MA, Feb15-17. Visit us at Booth #8092.

7

FEB

2024

MRU’s Center for Health and Innovation in Aging showcases how older populations benefit when industry, academia, and senior living providers collaborate.

31

JAN

2024

New Centre for Health and Innovation in Aging at MRU paving the way for older adults to be introduced to groundbreaking healthcare innovation from Neursantys.

01

JAN

2024

Join Neursantys for our “AI in Healthcare” product showcase at the JP Morgan Healthcare Conference on Jan 8, 2024 in San Francisco.

2023

04

DEC

2023

Neursantys to present at 2023 Biomarkers of Aging Symposium at the Buck Institute for Research on Aging, Novato, California, Dec 4th 2023.

20-21

NOV

2023

NEURVESTA bioelectronic platform to be showcased by Canadian Space Agency Nov 20-21 as finalist in Deep Space Healthcare Challenge.

Meet the Finalists

12

NOV

2023

Calgary PhD student partners with retirement community to test wearable fall-prevention technology for seniors.

10

NOV

2023

CBC Evening News covers successful Neursantys pilot deployment at United Active Living in Calgary with on-the-ground support from University of Calgary team.

09

NOV

2023

Neursantys and Jali Medical to Showcase NEURVESTA Bioelectronics Platform at Neuroscience 2023, Nov 11-15.

06-08

NOV

2023

Neursantys showcased NEURVESTA balance restoration pilot deployments with Senior Living providers at the CALA 2023 Fall Conference and Tradeshow.

01

NOV

2023

“Balancing Time: Aging, Neurotech, and the Science of Stability” – Listen to the podcast with Neursantys research partner University of Calgary. Available platforms: Apple or Spotify.

26-28

OCT

2023

University of Calgary and Neursantys to present results of NEURVESTA pilot deployments at the CAG2023 Annual Scientific and Educational Meeting in Toronto.

24-26

OCT

2023

Join Neursantys at Age-Well 2023 in Toronto for our presentation on “Wearable Bioelectronic Balance Restoration in Older Adults”.

23-24

OCT

2023

Join Neursantys at Biosensors for Medical Wearables in Boston for our presentation on electroceutical devices and treatments as an alternative to pharmaceuticals.

27

SEPT

2023

Neursantys selected as finalist in 2023 Humans in Space Challenge, will join Space Expansion Program and present at HIS Symposium in Las Vegas, Oct 23-25.

19

SEPT

2023

Bioelectronics Pioneer Neursantys Opens Silicon Valley Office, Joins LeadingAge California as Premier Business Partner.

5

SEPT

2023

Neursantys, United Active Living, and University of Calgary Deploy Innovative Treatment for Age-Related Balance Decline.

17

JULY

2023

Neursantys CEO John Ralston to present invited talk on “Integrating Diagnostic and Therapeutic Capabilities into Non-Invasive Wearable Solutions for the Management of Complex Neurological Conditions” at Neurotalk 2023, Lisbon, Portugal, July 17-19

9

JULY

2023

Neursantys and clinical partners to present results of 3 recent studies highlighting the company’s innovations in wearable balance diagnostics and non-invasive bioelectronic balance therapeutics at ISPGR 2023, Brisbane, Australia, July 9-13

4

JULY

2023

Startup Showcase: Neursantys, Inc. – Revolutionizing Balance Restoration with Innovative Wearable Devices

1

JUNE

2023

Neursantys clinical neurology research partner University of Victoria to present exciting new results at CMSC-2023 Annual Meeting: “Relationship between Phybrata Wearable Sensor Data and White Matter Microstructure in People with Multiple Sclerosis”

15

MAY

2023

Neursantys to present “NEURVESTA: wearable remote management of balance impairments caused by aging and microgravity” at Canadian Lunar Workshop 2023.

28

APRIL

2023

Neursantys awarded $350,000 by Canadian Space Agency to move on to Stage 3 of the Deep Space Healthcare Challenge.

14

APRIL

2023

Neursantys to Present at Society for the Neural Control of Movement Annual Meeting (NCM 2023), April 17-21, Victoria, British Columbia.

22

MARCH

2023

Neursantys Leadership Team Discusses Policies to Boost Age-Tech Innovations in Canada.

14

MARCH

2023

Bioelectronics Pioneer Neursantys Expands Executive Team, Advisory Board, and Investor Base.

7

MARCH

2023

NEURVESTA bioelectronic wearable selected as finalist for Product Design of the Year award.

16

FEB

2023

Neursantys and other semi-finalists in Canadian Space Agency Deep Space Healthcare Challenge share their solutions, inspirations, and experiences with Impact Canada.

10

FEB

2023

Chief Science Officer Ryan Peters and CEO John Ralston to showcase Neursantys innovations at the Hotchkiss Brain Institute NEUROVATION event in Calgary.

2

FEB

2023

Neursantys and University of Calgary research into improving balance and gait mobility in older adults could help those with neurological impairments like stroke and Parkinson’s disease.

2022

8

DEC

2022

Neursantys CEO John Ralston to join “Mobility for an Aging Population” panel at Washington D.C. Longevity Innovation Summit

30

NOV

2022

Dual-use remote care applications of NEURVESTA to be showcased at Canadian Space Agency 2022 Health Beyond Summit

24

NOV

2022

Neursantys and University of Calgary Pilot Wearable Device to Treat Age-Related Balance Decline

4

NOV

2022

Neursantys selected to present to investors at the 2022 Silicon Valley Leaders Forum HealthTech Showcase

20

OCT

2022

Neursantys announces know-how agreement with Mayo Clinic

18

OCT

2022

Neursantys CEO John Ralston to present at BIOSENSORS FOR MEDICAL WEARABLES, 24-25 October 2022, Boston, USA Title: “Wearable device integration of neurophysiological
diagnostic and therapeutic capabilities”

20

July

2022

Neursantys Establishes Advisory Board, Announces New Members.

11

July

2022

University of Calgary researchers highlight potential application of NEURVESTA device to address increased motion sickness that often accompanies aging.

30

June

2022

Neursantys Wins $10K Business Plan Competition at 2022 What’s Next Longevity Venture Summit

17

June

2022

Neursantys to showcase the NEURVESTA wearable at mHUB’s 5 Year Anniversary Product Showcase in Chicago on June 23rd

8

June

2022

Congratulations to Neursantys for winning the 19th Annual What’s Next Longevity Venture Summit Business Plan Competition.

25

MAY

2022

Canadian Space Agency selects Neursantys as semi-finalist in Deep Space Healthcare Challenge to develop innovative healthcare technologies for remote communities and long duration space missions

24

MAY

2022

Neursantys selected as Finalist in 19th Annual What’s Next Longevity Venture Summit Business Plan Competition.

10

MAR

2022

Neursantys to present at MedCity INVEST, the premier national healthcare investing conference, March 28-30, 2022, Chicago

28

Feb

2022

Neursantys CEO John Ralston to present at 12th Annual Neurotalk Global Congress, June 15-17, 2022, Singapore

Title: “Integrating Diagnostic and Therapeutic Capabilities into Non-Invasive Wearable Solutions for the Management of Complex Neurological Conditions”

2021

07

Dec

2021

PROTXX Phybrata Sensor Technology Selected by Neursantys for Wearable Neuroprosthetic Device

30

Nov

2021

Neursantys Selected for mHUB Premier MedTech Accelerator Cohort in Chicago

10

Nov

2021

mHUB Announces Portfolio Teams of Premier MedTech Accelerator Cohort

Startups to Participate in the Chicago-Based Program Are Developing Novel Solutions for Patient Monitoring, Drug Delivery and Therapeutic Devices